|
HSPH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.838000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.249400E-01 |
| Normal-vs-Stage2 |
1.268240E-01 |
| Normal-vs-Stage3 |
2.332600E-01 |
| Normal-vs-Stage4 |
4.273400E-01 |
| Stage1-vs-Stage2 |
3.061800E-02 |
| Stage1-vs-Stage3 |
2.699600E-01 |
| Stage1-vs-Stage4 |
4.957000E-01 |
| Stage2-vs-Stage3 |
2.071600E-01 |
| Stage2-vs-Stage4 |
2.486000E-02 |
| Stage3-vs-Stage4 |
1.528040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.138000E-01 |
| Normal-vs-AfricanAmerican |
2.244600E-01 |
| Normal-vs-Asian |
4.572800E-01 |
| Caucasian-vs-AfricanAmerican |
4.493800E-01 |
| Caucasian-vs-Asian |
3.479800E-01 |
| AfricanAmerican-vs-Asian |
2.127400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.018800E-01 |
| Normal-vs-Female |
2.795000E-01 |
| Male-vs-Female |
8.248000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.686000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.514000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.459210E-01 |
| Normal-vs-Age(81-100Yrs) |
1.832220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.555700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.804800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.311000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.184190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.653600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.969800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.367050E-01 |
| Classical-VS-Follicular |
4.46975789714088E-13 |
| Classical-VS-Other |
3.659000E-01 |
| Classical-VS-Normal |
4.807600E-01 |
| Tall-VS-Follicular |
2.819300E-04 |
| Tall-VS-Other |
8.113000E-01 |
| Tall-VS-Normal |
2.971200E-01 |
| Follicular-VS-Other |
1.153550E-01 |
| Follicular-VS-Normal |
3.672400E-02 |
| Other-VS-Normal |
3.153600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.629160E-01 |
| Normal-vs-N1 |
3.202000E-01 |
| N0-vs-N1 |
1.176820E-01 |
|
|
